166 related articles for article (PubMed ID: 17320212)
1. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.
Gürgün C; Ildizli M; Yavuzgil O; Sin A; Apaydin A; Cinar C; Kültürsay H
Int J Cardiol; 2008 Jan; 123(2):102-7. PubMed ID: 17320212
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
[TBL] [Abstract][Full Text] [Related]
4. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
[TBL] [Abstract][Full Text] [Related]
5. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
7. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.
Sola S; Mir MQ; Rajagopalan S; Helmy T; Tandon N; Khan BV
J Card Fail; 2005 Oct; 11(8):607-12. PubMed ID: 16230264
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin and fluvastatin reduce viremia and the pro-inflammatory cytokines in the patients with chronic hepatitis C.
Mihăilă R; Nedelcu L; Frăţilă O; Rezi EC; Domnariu C; Ciucă R; Zaharie AV; Olteanu A; Bera L; Deac M; Mihăilă R
Hepatogastroenterology; 2009; 56(96):1704-9. PubMed ID: 20214221
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
[TBL] [Abstract][Full Text] [Related]
11. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
12. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD
Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
[TBL] [Abstract][Full Text] [Related]
15. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM
Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
Horwich TB; MacLellan WR; Fonarow GC
J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
[TBL] [Abstract][Full Text] [Related]
17. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
18. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
Lye M; Valacio R; Reckless JP; Ghosh AK; Findlay IN; Ghosh MK; Passmore AP; Fulcher RA
Coron Artery Dis; 1998; 9(9):583-90. PubMed ID: 9861520
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
Yasue H; Mizuno Y; Harada E; Itoh T; Nakagawa H; Nakayama M; Ogawa H; Tayama S; Honda T; Hokimoto S; Ohshima S; Hokamura Y; Kugiyama K; Horie M; Yoshimura M; Harada M; Uemura S; Saito Y;
J Am Coll Cardiol; 2008 May; 51(18):1742-8. PubMed ID: 18452779
[TBL] [Abstract][Full Text] [Related]
20. Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.
Bové T; Van Belleghem Y; Vandenplas G; Caes F; François K; De Backer J; De Pauw M; Van Nooten G
Eur J Cardiothorac Surg; 2009 Jun; 35(6):995-1003; discussion 1003. PubMed ID: 19136274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
